Hepatic Disease in HIV-Infected Patients

  • Author: Mark S. Sulkowski, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 9/4/18 (What's New)

Summary

  • Prevalence of HCV coinfection varies depending on the route of HIV transmission, ranging from 10% to 14% among persons reporting high-risk sexual exposure to approximately 85% to 90% among those reporting injection drug use[Sulkowski 2003; Vandelli 2004]
  • In the United States and Europe, approximately 25% to 33% of all HIV-infected persons are HCV infected[Kim 2013; Rockstroh 2005]
  • Among HIV-infected men, 75% of individuals who seroconvert to become HCV positive are infected by nonparenteral means[Taylor 2011]

Action required

Keywords: Hepatic Complications, IV Drug Use, Sexually Transmitted Diseases, Special Populations, Viral Hepatitis Coinfection

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.